209 related articles for article (PubMed ID: 22024794)
1. Carbon monoxide and nitric oxide modulate α₂-antiplasmin and plasmin activity: role of heme.
Arkebauer MR; Kanaparthy SS; Malayaman SN; Vosseller K; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):712-9. PubMed ID: 22024794
[TBL] [Abstract][Full Text] [Related]
2. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
3. The antifibrinolytic effects of carbon monoxide-releasing molecule-2 are fibrin and alpha2-antiplasmin dependent.
Nielsen VG
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):584-7. PubMed ID: 20683324
[TBL] [Abstract][Full Text] [Related]
4. Fibrinogen is a heme-associated, carbon monoxide sensing molecule: a preliminary report.
Nielsen VG; Cohen JB; Malayaman SN; Nowak M; Vosseller K
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):443-7. PubMed ID: 21451399
[TBL] [Abstract][Full Text] [Related]
5. Thrombelastographic characterization of coagulation/fibrinolysis in horses: role of carboxyheme and metheme states.
Olver CS; Nielsen VG
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):273-8. PubMed ID: 23222168
[TBL] [Abstract][Full Text] [Related]
6. Redox-based thrombelastographic method to detect carboxyhemefibrinogen-mediated hypercoagulability.
Nielsen VG; Arkebauer MR; Vosseller K
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):657-61. PubMed ID: 21822126
[TBL] [Abstract][Full Text] [Related]
7. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma.
Nielsen VG; Kirklin JK; George JF
Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyethyl starch enhances fibrinolysis in human plasma by diminishing alpha2-antiplasmin-plasmin interactions.
Nielsen VG
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):647-56. PubMed ID: 17890952
[TBL] [Abstract][Full Text] [Related]
9. Iron and carbon monoxide attenuate Crotalus atrox venom-enhanced tissue-type plasminogen activator-initiated fibrinolysis.
Nielsen VG; Boyer LV; Matika RW; Amos Q; Redford DT
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):511-6. PubMed ID: 26575490
[TBL] [Abstract][Full Text] [Related]
10. Can divergent plasmin-antiplasmin-carbon monoxide interactions in young, healthy tobacco smokers explain the 'smoker's paradox'?
Nielsen VG; Hafner DT; Steinbrenner EB
Blood Coagul Fibrinolysis; 2013 Jun; 24(4):381-5. PubMed ID: 23429256
[TBL] [Abstract][Full Text] [Related]
11. Quantification of the effects of thrombin activatable fibrinolysis inhibitor and alpha2-antiplasmin on fibrinolysis in normal human plasma.
Nielsen VG; Ellis TC
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):29-33. PubMed ID: 17179823
[TBL] [Abstract][Full Text] [Related]
12. Freezing does not decrease carbon monoxide-mediated hypercoagulation and hypofibrinolysis in human plasma.
Nielsen VG; Hafner DT
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):784-6. PubMed ID: 22964769
[TBL] [Abstract][Full Text] [Related]
13. Carbon monoxide releasing molecule-2 enhances coagulation and attenuates fibrinolysis by two mechanisms: insights gained with colloid dilution.
Cohen JB; Persaud JM; Malayaman SN; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jan; 22(1):60-6. PubMed ID: 21157300
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
15. An enzyme-linked immunosorbent assay (ELISA) for the measurement of plasmin-alpha 2-antiplasmin complex in human plasma--application to the detection of in vivo activation of the fibrinolytic system.
Holvoet P; de Boer A; Verstreken M; Collen D
Thromb Haemost; 1986 Oct; 56(2):124-7. PubMed ID: 2433784
[TBL] [Abstract][Full Text] [Related]
16. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
17. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
18. Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
Walker JB; Bajzar L
J Thromb Haemost; 2007 Jun; 5(6):1257-64. PubMed ID: 17389009
[TBL] [Abstract][Full Text] [Related]
19. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
20. Extrinsic plasminogen activator: a new principle in fibrinolysis.
Lijnen HR
Behring Inst Mitt; 1983 Aug; (73):43-55. PubMed ID: 6236789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]